Scroll To Top

yeztugo

On World AIDS Day, thinking of progress and how to build on it in the face of hostility

“As long as people willing to fight, we will change the course of history,” says HRC's Matthew Rose.

Gavin Newsom signs several pro-LGBTQ+ laws, vetoes gender-affirming care and HIV coverage

Here are the LGBTQ+ bills Gavin Newsom signed or vetoed this week.

CVS Health denies coverage for  breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."

FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent

Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.

CVS tells HIV activists that pharma company Gilead needs to lower price of PrEP drug if it wants it covered

A CVS executive told PrEP4All by email that the $28,000 price on a drug sold for $40 overseas was unacceptable.

It’s National PrEP Day! Learn the latest about HIV prevention

There are now more ways than ever — including long-acting injectables — to prevent the spread of HIV.